Jerry Colca

Company: Cirius Therapeutics

Job title: Chief Scientific Officer

Seminars:

New Insulin Sensitizers as a Golden Combination With Glp-1 & Weight Loss Therapies 9:00 am - 10:00 am

Discussing novel oral insulin sensitizers targeting the mitochondrial pyruvate carrier to improve insulin sensitivity by shifting mitochondrial metabolism, increasing insulin response, and enhancing mitochondrial function Exploring insulin sensitizers beyond glycaemic control such as their potential to increase lean muscle mass and inflammation modulation Developing potent insulin-sensitising drugs that can be used in combination with GLP-1…Read more

day: Day One